Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CXCR2 | P25025 | 3/20 | 0.51 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29642859 | 1.00 | GAA (1.00) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL11900810 | 0.86 | GAA (0.76) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL16197958 | 0.84 | KDM4E (0.72) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL12407368 | 0.83 | KDM4E (0.71) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL2644882 | 0.83 | GAA (0.70) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL1761791 | 0.83 | KDM4E (0.70) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL13750111 | 0.81 | ALDH1A1 (0.69) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL28248993 | 0.81 | KDM4E (0.68) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL12655635 | 0.80 | KDM4E (0.66) | GAAKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL5645453 | 0.79 | ALDH1A1 (0.66) | GAAKDM4EALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136628-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-05-01 | — | — | US | disclosed |
| CN-114933614-A | Organic electroluminescent material and device | 环球展览公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-105820122-B | Organic electroluminescent material and device | 环球展览公司 | 2022-05-17 | — | — | CN | disclosed |
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| CN-105820122-A | Organic electroluminescent material and device | 环球展览公司 | 2016-08-03 | — | — | CN | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
| US-7622594-B2 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20070060633-A1 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136628-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRD1 | GAA 4278/4885KDM4E 1990/4885ALDH1A1 1023/4885 |
| US-20070060633-A1 | Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | NR3C1, MC2R, NR3C2 | GAA 1264/4885KDM4E 4087/4885ALDH1A1 2756/4885 |
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | GAA 2911/4885KDM4E 4426/4885ALDH1A1 1620/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | GAA 2911/4885KDM4E 4426/4885ALDH1A1 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.